- National Antibiotic Guideline (NAG), 2nd Edition
- The Cost of Diabetes Care for Ambulatory Patients in Malaysian Ministry of Health Facilities
- 8th National Pharmacy R&D Conference, 2014
- Master Plan of Action - Malaysia National Medicines Policy 2nd Edition
- Seminar on the Introduction of the New Guideline for Medicines Advertisements
Pharmaceutical Services Division, Ministry of Health Malaysia
Lot 36, Jalan Universiti, 46350 Petaling Jaya, Selangor.
[ Location map ]
Phone: 603-7841 3200
Fax: 603-7968 2222
You are here
Malaysian National Medicines Policy (DUNAS)
The Malaysian National Medicines Policy is an official document of the Government of Malaysia, which defines and prioritizes the medium- and long-term goals set by the government for the pharmaceutical sector, and identifies the main strategies for attaining them. It provides the basic framework within which the activities of the pharmaceutical sector can be coordinated by both the public and private sectors.
The objective of the MNMP is to to improve health outcomes of the people through:
- Promoting equitable access to essential medicines.
- Promoting rational use of safe, effective and affordable essential medicines of good quality.
The MNMP has 8 components, comprising of 4 core components and 4 supportive components, as follows:
1. Quality, safety and efficacy of drugs
2. Drug availability
3. Drug affordability
4. Quality use of drugs
5. Human resource development
6. Research and development
7. Technical cooperation
8. Management of the National Medicines Policy
Full term review of Malaysian National Medicine Policy
The policy has been fully reviewed in October 2012 after six years of implementation. The draft of the revised policy has been produced and is currently awaiting approval from the higher management of the Ministry of Health. The revised policy will be uploaded into this website once it has been approved.